SEC Comment Letter for PAVmed Inc. (PAVM) (CIK 0001624326) (PAVM) — Oct 12, 2018
PAVmed Inc. (PAVM) (CIK 0001624326)
Date: Oct. 12, 2018 · CIK: 0001624326 · Accession: 0000000000-18-032181
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227718
Letter
October 12, 2018 Lishan Aklog, M.D. Chairman of the Board PAVmed Inc. One Grand Central Place, Suite 4600 New York, New York 10165 Re:PAVmed Inc. Registration Statement on Form S-3 Filed October 5, 2018 File No. 333-227718 Dear Dr. Aklog: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Thomas Jones at 202-551-3602 with any questions. Sincerely, Division of Corporation Finance Office of Electronics and Machinery cc: Jeffrey M. Gallant, Esq.
Show Raw Text
October 12, 2018
Lishan Aklog, M.D.
Chairman of the Board
PAVmed Inc.
One Grand Central Place, Suite 4600
New York, New York 10165
Re:PAVmed Inc.
Registration Statement on Form S-3
Filed October 5, 2018
File No. 333-227718
Dear Dr. Aklog:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Thomas Jones at 202-551-3602 with any questions.
Sincerely,
Division of Corporation Finance
Office of Electronics and Machinery
cc: Jeffrey M. Gallant, Esq.